A detailed history of Proathlete Wealth Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Proathlete Wealth Management LLC holds 23 shares of NVO stock, worth $1,114. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23
Previous 31 25.81%
Holding current value
$1,114
Previous $2.14 Million 40.35%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 07, 2025

SELL
$45.38 - $71.7 $363 - $573
-8 Reduced 25.81%
23 $1.28 Million
Q2 2025

Jul 14, 2025

BUY
$58.08 - $81.05 $1,568 - $2,188
27 Added 675.0%
31 $2.14 Million
Q1 2025

Apr 21, 2025

BUY
$69.3 - $90.95 $277 - $363
4 New
4 $277,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Proathlete Wealth Management LLC Portfolio

Follow Proathlete Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proathlete Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proathlete Wealth Management LLC with notifications on news.